ASTRO Annual Meeting

American Society for Radiation Oncology chose Corey J. Langer, MD, as its 2019 honorary member. The award is the highest honor that ASTRO bestows…

Ultra-hypofractionated stereotactic body radiotherapy did not appear to increase acute toxicity compared with conventionally fractionated therapy…

The American Society for Radiation Oncology honored three of its members with the Gold Medal Award. This year’s recipients were Walter J…

Durvalumab extended the time to first progression and reduced the risk for local and distant progression among patients with unresectable stage III…

Stereotactic ablative radiation appeared to be an effective and safe treatment for men with oligometastatic prostate cancer, with significant…

Patients who received radiation therapy before chimeric antigen receptor T-cell therapy for relapsed or refractory non-Hodgkin lymphoma were less…

The addition of stereotactic body radiotherapy after progression on pembrolizumab prolonged PFS among patients with metastatic non-small cell lung…

Long-term antiandrogen therapy did not improve OS when administered during early salvage radiation therapy among patients with recurrent prostate…

Whole-breast radiation significantly decreased local recurrence and invasive local recurrence among a subset of women with favorable-riskductal…

Women with early breast cancer who received once-weekly, hypofractionated radiotherapy exhibited low rates of normal tissue effects comparable to…